New Pharmac drugs will 'significantly' impact quality of life for cancer patients - PM
New drugs for lung cancer and breast cancer, as well as a new treatment for multiple sclerosis will be funded by Pharmac, the Government announced today. In addition, access to a treatment for respiratory disease - pirfenidone, known by brand name Esbriet - will be widened. The drugs for non-small cell lung cancer and HER-2 positive metastatic breast cancer will be available from December 1. Health Minister David Clark said the drug funding would help 420 people, "including people living with advanced cancer". "Pharmac is currently consulting on three more cancer drugs - olaparib (Lynparza) for ovarian cancer, fulvestrant (Faslodex) for breast cancer and venetoclax (Venclexta) for chronic lymphocytic leukaemia," he said in a statement. The drugs funded from December 1 will be alectinib, known as Alecensa, for ALK positive advanced non-small cell lung cancer and trastuzumab emtansine, which goes by brand name Kadcyla, for HER-2 positive metastatic breast cancer.
"It will take time to modernise our approach to cancer care and control and improve survival rates, but today signifies good progress on the delivery of our plan," Mr Clark said.
==========================================================
Poll: If we want to reduce speeding, what do you think actually changes driver behaviour? π»π¨π
In the Post's article on speeding penalties, the question is asked whether speeding fines are truly about road safety, or are they just a way to boost revenue for the Crown?
What do you think? Should speeding motorists receive speeding fines or demerit points?
-
38.2% The sting of a fine (Money talks!)
-
61.8% The threat of demerit points (Nobody wants to lose their license!)
Some Choice News!
DOC is rolling out a new tool to help figure out what to tackle first when it comes to protecting our threatened species and the things putting them at risk.
Why does this matter? As Nikki Macdonald from The Post points out, weβre a country with around 4,400 threatened species. With limited time and funding, conservation has always meant making tough calls about what gets attention first.
For the first time, DOC has put real numbers around what it would take to do everything needed to properly safeguard our unique natural environment. The new BioInvest tool shows the scale of the challenge: 310,177 actions across 28,007 sites.
Now that we can see the full picture, it brings the big question into focus: how much do we, as Kiwis, truly value protecting nature β and what are we prepared to invest to make it happen?
We hope this brings a smile!
π Riddle me this, legends! π
He/She who makes it, sells it.
He/She who buys it, doesn't use it.
The user doesn't know they are using it.
What is it?
(Shezz from NgΔruawΔhia kindly provided this head-scratcher ... thanks, Shezz!)
Do you think you know the answer? Simply 'Like' this post if you know the answer and the big reveal will be posted in the comments at 2pm on the day!
Want to stop seeing these in your newsfeed?
Head here and hover on the Following button on the top right of the page (and it will show Unfollow) and then click it. If it is giving you the option to Follow, then you've successfully unfollowed the Riddles page.
Loading…
